Characterization of the aggregation-prevention activity of p97/valosin-containing protein

被引:29
|
作者
Song, Changcheng [1 ,2 ]
Wang, Qing [1 ]
Li, Chou-Chi H. [1 ,2 ]
机构
[1] NCI, Lab Canc Prevent, Frederick, MD 21702 USA
[2] SAIC Frederick Inc, Basic Res Program, Frederick, MD USA
关键词
D O I
10.1021/bi700499j
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The 97 kDa valosin-containing protein (VCP) belongs to a highly conserved AAA (ATPases associated with a variety of activities) family and contains two ATPase domains, D1 and D2. VCP participates in numerous cellular activities, such as membrane fusion, postmitotic Golgi reassembly, endoplasmic reticulum-associated degradation, ubiquitin-proteasome-mediated proteolysis, and many others. In performing these activities, VCP presumably acts as a molecular chaperone that prevents protein aggregation and modifies protein conformation. In this study, we characterized the aggregation-prevention activity of VCP and identified the structural requirement for this activity. We used multiple methods to treat aggregation-prone luciferase (Luc) and showed that VCP prevents the aggregation of Luc in vitro. These results are in agreement; in vivo RNA interference analyses showed that a reduction of VCP level results in more aggregation of Luc in cells. Structural and functional analyses further demonstrated that the D I domain of VCP is sufficient to mediate the aggregation-prevention activity, which does not require ATP binding, ATP hydrolysis, or a hexameric structure of VCP. Together, these results indicate that (1) VCP prevents protein aggregation in vitro and in vivo, (2) this aggregation-prevention activity is mediated mainly through the D I domain of VCP, and (3) this activity does not require ATPase activity or a hexameric structure of VCP.
引用
收藏
页码:14889 / 14898
页数:10
相关论文
共 50 条
  • [31] Valosin-Containing Protein (VCP/p97) Is Required for Poliovirus Replication and Is Involved in Cellular Protein Secretion Pathway in Poliovirus Infection
    Arita, Minetaro
    Wakita, Takaji
    Shimizu, Hiroyuki
    JOURNAL OF VIROLOGY, 2012, 86 (10) : 5541 - 5553
  • [32] Valosin-containing protein (VCP/p97) inhibition reduces viral clearance and induces toxicity associated with muscular damage
    Marta del Rio Oliva
    Michael Basler
    Cell Death & Disease, 13
  • [33] Increased Expression of Valosin-Containing Protein (p97) is Associated With Lymph Node Metastasis and Prognosis of Pancreatic Ductal Adenocarcinoma
    Shinji Yamamoto
    Yasuhiko Tomita
    Yoshihiko Hoshida
    Hiroaki Nagano
    Keizo Dono
    Koji Umeshita
    Masato Sakon
    Osamu Ishikawa
    Hiroaki Ohigashi
    Shoji Nakamori
    Morito Monden
    Katsuyuki Aozasa
    Annals of Surgical Oncology, 2004, 11 : 165 - 172
  • [34] Differential expression of valosin-containing protein (VCP, P97) in acute lymphoblastic leukemia cells with and without glucocorticoid treatment
    von Neuhoff, N.
    Junk, S.
    Cario, G.
    Wittner, N.
    Schrappe, M.
    Schlegelberger, B.
    Lauten, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 8 - 8
  • [35] Structural basis for recognition and methylation of p97 by METTL21D, a valosin-containing protein lysine methyltransferase
    Nguyen, Thang Quyet
    Koh, Seri
    Kwon, Jiin
    Jang, Soyeon
    Kang, Wonchull
    Yang, Jin Kuk
    ISCIENCE, 2023, 26 (07)
  • [36] Valosin-containing protein (VCP/p97) inhibition reduces viral clearance and induces toxicity associated with muscular damage
    del Rio Oliva, Marta
    Basler, Michael
    CELL DEATH & DISEASE, 2022, 13 (12)
  • [37] The AAA plus ATPase valosin-containing protein (VCP)/p97/Cdc48 interaction network in Leishmania
    Aguiar, Bruno Guedes
    Dumas, Carole
    Maaroufi, Halim
    Padmanabhan, Prasad K.
    Papadopoulou, Barbara
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [38] Valosin-containing protein VCP/p97 is essential for the intracellular development of Leishmania and its survival under heat stress
    Aguiar, Bruno Guedes
    Padmanabhan, Prasad K.
    Dumas, Carole
    Papadopoulou, Barbara
    CELLULAR MICROBIOLOGY, 2018, 20 (10)
  • [39] 2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97)
    Bursavich, Matthew G.
    Parker, Daniel P.
    Willardsen, J. Adam
    Gao, Zhong-Hua
    Davis, Thaylon
    Ostanin, Kirill
    Robinson, Rosann
    Peterson, Ashley
    Cimbora, Daniel M.
    Zhu, Ju-Fen
    Richards, Burt
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (05) : 1677 - 1679
  • [40] A novel function of VCP (valosin-containing protein; p97) in the control of N-glycosylation of proteins in the endoplasmic reticulum
    Lass, Agnieszka
    McConnell, Elizabeth
    Nowis, Dominika
    Mechref, Yehia
    Kang, Pilsoo
    Novotny, Milos V.
    Wojcik, Cezary
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2007, 462 (01) : 62 - 73